Kothari Fermentation & Biochem Intrinsic Value
Kothari Fermentation & Biochem intrinsic value. Kothari Fermentation & Biochem (KFBL) median intrinsic value is ₹36.00 from 4 valuation models (range ₹31–₹64), vs current price ₹40.62 — -11.4% downside (Trading Above Median Value), margin of safety -12.8%. Compare with Kothari Fermentation & Biochem value estimation to assess whether the stock is under or overvalued.
KFBL Valuation Methods Summary — DCF, Graham Number & P/E
Kothari Fermentation & Biochem intrinsic value across 4 models vs current price ₹40.62 — upside/downside and value range per method. Read Kothari Fermentation & Biochem dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹36.00 | ₹32.40 - ₹39.60 | -11.4% | Book Value/Share: ₹36.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹64.00 | ₹57.60 - ₹70.40 | +57.6% | Revenue/Share: ₹80.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹32.00 | ₹28.80 - ₹35.20 | -21.2% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹30.95 | ₹24.76 - ₹37.14 | -23.8% | CF Growth: 5.0%, Discount: 15% |
KFBL Intrinsic Value vs Market Price — All Valuation Models
Kothari Fermentation & Biochem fair value range ₹31–₹64 vs current market price ₹40.62 across 4 valuation models. For current market price and key ratios, visit Kothari Fermentation & Biochem share price screener.
KFBL Intrinsic Value Analysis — Undervalued or Overvalued?
Kothari Fermentation & Biochem median intrinsic value ₹36.00, current price ₹40.62 — Trading Above Median Value by 11.4%, margin of safety -12.8%.
What is the intrinsic value of KFBL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Kothari Fermentation & Biochem (KFBL) is ₹36.00 (median value). With the current market price of ₹40.62, this represents a -11.4% variance from our estimated fair value.
The valuation range spans from ₹30.95 to ₹64.00, indicating ₹30.95 - ₹64.00.
Is KFBL undervalued or overvalued?
Based on our multi-method analysis, Kothari Fermentation & Biochem (KFBL) appears to be trading above median value by approximately 11.4%.
KFBL Financial Health — Key Ratios vs Industry Benchmarks
Kothari Fermentation & Biochem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.62 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -3.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.94x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KFBL Cash Flow Quality — Operating & Free Cash Flow
Kothari Fermentation & Biochem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹5 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹11 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹9 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹10 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |